Skip to main content
Clinical Trials/NCT00586950
NCT00586950CompletedNot Applicable

Outcome Study on BMIPP SPECT Analysis for Decreasing Cardiac Events in Hemodialysis Patients

Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan1 site in 1 country1,000 target enrollmentStarted: June 2006Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
1,000
Locations
1

Study Overview

Brief Summary

The aim of this multi-center study is to determine the applicability of BMIPP to diagnosing cardiac disease and to predicting the outcome of patients on hemodialysis.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
20 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adult hemodialysis patients with one or more of the following 10 risk factors for coronary heart disease
  • Hypertension
  • Diabetes mellitus
  • Hyperlipidemia
  • Obliterative arteriosclerosis in the lower extremities
  • Family history of juvenile coronary artery disease
  • History of ischemic stroke
  • History of heart failure requiring hospitalization
  • Within 3 months after initiation of hemodialysis therapy
  • Dialysis hypotension

Exclusion Criteria

  • Hemodialysis patients who meet any one of the following conditions will be excluded.
  • Peritoneal dialysis
  • Severe valvular disorder requiring treatment
  • Diagnosis of hypertrophic cardiomyopathy(HCM) or dilated cardiomyopathy(DCM) before start of dialysis
  • History of revascularization(PCI, CABG) or prior diagnosis of myocardial infarction
  • Hypersensitivity to BMIPP or its analogue
  • Judged unsuitable for the study for any other reasons by physicians.

Investigators

Sponsor
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Sponsor Class
Other

Study Sites (1)

Loading locations...

Similar Trials